English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThis World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on the health care community to increase lung cancer screening for people with HIV who are current or former heavy smokers and may be at high risk for developing the disease. As HIV- infected individuals have high smoking rates, smoking cessation should also be encouraged.
Tag: HIV
HIV Infection Leaves a ‘Memory’ in Cells
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of their lives.
HIV, AIDS training center at UIC goes national with help of $3M grant
The Midwest AIDS Training and Education Center at the University of Illinois Chicago will expand its services nationwide with the help of a new $3 million grant.
Addressing stigma is critical to containing the monkeypox outbreak
Inaccurate media coverage of the monkeypox outbreak has resulted in misinformation about the many ways it can be spread, resulting in stigma (shaming and biased attitudes) toward people who develop the disease. Nurses play a key role in delivering appropriate care related to monkeypox by creating safe spaces for affected individuals regardless of sexual behaviors, race and ethnicity, gender, or co-infections. These conclusions come from two papers in the November/December issue of The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
Mount Sinai’s Yvette Calderon, MD, MS, Elected to National Academy of Medicine for Contributions to Emergency Medicine
Yvette Calderon, MD, MS, Chair of Emergency Medicine at Mount Sinai Beth Israel and Professor of Emergency Medicine at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Medicine (NAM). Election to the NAM is considered one of the highest honors in health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service. With her election, Mount Sinai has 26 faculty members in the NAM.
Risk of Severe Breakthrough COVID-19 Infection Is Higher for People With HIV With Moderately Low CD4 Cell Counts
People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 “breakthrough” infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Gut bacteria may contribute to susceptibility to HIV infection, UCLA-led research suggests
New UCLA-led research suggests certain gut bacteria — including one that is essential for a healthy gut microbiome – differ between people who go on to acquire HIV infection compared to those who have not become infected. The findings, published in the peer-reviewed journal eBioMedicine, suggest that the gut microbiome could contribute to one’s risk for HIV infection, said study lead Dr.
The longer the bootcamp, the better the antibodies
LJI research shows that a “slow delivery, escalating dose” vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
Researchers Receive $4.2M Grant to Improve PrEP Access and Prevent New HIV Infections
Bronx county has the country’s fifth-highest rate of HIV diagnosis—but the lowest rate in New York State for use of HIV pre-exposure prophylaxis (PrEP), medications that are extremely effective in preventing HIV infection. Physician-researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $4.2 million grant from the National Institutes of Health to compare two strategies for improving PrEP access and use in the Bronx.
Dolutegravir-Based Antiretroviral Therapies for HIV-1 Effective in Pregnancy
Dolutegravir-based antiretroviral therapy (ART) for HIV-1 infection is more effective in pregnancy than some other ART regimens commonly used in the U.S. and Europe, according to a study published in the New England Journal of Medicine.
State-level Earned Income Tax Credit linked to reduction in high-risk HIV behavior among single mothers
UCLA research finds that a refundable State-level Earned Income Tax Credit (SEITC) of 10% or above the Federal EITC was associated with a 21% relative risk reduction in reported behavior that could put single mothers at high risk for becoming infected with HIV during the previous year. Also, a 10 percentage-point increase in SEITC was linked to a 38% relative reduction in the same reported high-risk behavior the previous year.
Cancer and HIV
Sylvester Comprehensive Cancer Center researcher Emmanuel Thomas, M.D., Ph.D., F.A.A.S.L.D., has been appointed to the National Institutes of Health’s (NIH) Coinfections and HIV Associated Cancers (HCAC) study section.
Additional Antibody Mediated Prevention (AMP) trials data published in Nature Medicine
An embargoed study published in the Aug. 22, 2022 issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1, the most common type of the virus that causes AIDS. Broadly neutralizing antibodies (bnAbs) are defined by their ability to neutralize multiple genetically distinct viral strains.
U of U Health-Led Research Awarded $28 Million to Explore HIV’s Inner Workings and Vulnerabilities
A University of Utah Health-led multi-institutional research center that studies the inner workings and vulnerabilities of HIV, the human immunodeficieny virus that causes AIDS, recently received a five-year, $28 million grant renewal from the National Institutes of Health.
Journal Special Issue Offers Evidence and Guidance Supporting National PrEP Program to Turn Tide on HIV
Special issue includes research and commentary addressing important considerations for national PrEP program that would lower prices and expand access.
New insights into HIV latent cells yield potential cure targets
In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.
Beyond the blood-brain barrier: HIV research at Texas Biomed gets NIH funding boost
Texas Biomed has received a $3.9 million NIH grant to explore how gene-editing technology may help eradicate HIV in the brain.
Sylvester Plays Pivotal Role in Practice-Changing Anal Cancer Prevention Study Published by NEJM
The New England Journal of Medicine (NEJM) has published the results of a study by Sylvester Comprehensive Cancer Center at the University of Miami Miller School and other investigators on anal cancer prevention in people living with HIV (PLHIV) that will likely establish a…
Mathematical Model Helps Predict Anal Cancer Risk in Persons with HIV Infection
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
Study shows HIV speeds up body’s aging processes soon after infection
HIV has an “early and substantial” impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection.
PrEP Stigma Still High Among Men Who Have Sex With Men
Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the number of male couples who decide to adopt PrEP. These conclusions come from a study reported in the July/August issue of The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
Risk of Breakthrough COVID-19 Infection after Vaccination Is Higher Among People with HIV
Finding suggests that all people with HIV might benefit from additional dose in primary vaccination.
New tool integrates microbiome and host genetic sequencing analysis
A new software tool makes it easier to study relationships between a host, its microbiome and pathogens like HIV or SARS-CoV-2.
Wonder of Wonders, Miracle of Miracles: The Unprecedented Speed of COVID-19 Science
Article title: Wonder of Wonders, Miracle of Miracles: The Unprecedented Speed of COVID-19 Science Author: Michael Saag From the author: “Although a wide variety of scientific disciplines established the platform upon which the remarkable response to COVID-19 was based, the study…
Tip Sheet: Studies on COVID-19, TV and Toddler Diet Among Johns Hopkins Research to Be Featured at National Pediatrics Meeting
What: Pediatric Academic Societies (PAS) 2022 Meeting
When: April 21 to 25
Where: Colorado Convention Center (700 14th St., Denver, CO 80202)
Cinco maneiras pelas quais pacientes imunocomprometidos podem se proteger da COVID-19
Conforme as famílias se reúnem para as festas de final de ano, é importante que os pacientes imunocomprometidos tomem medidas extras para ajudar a se proteger da COVID-19. Pessoas com o sistema imunológico enfraquecido correm maior risco de adoecer gravemente com a COVID-19.
New Study Suggests Healthcare Provider Biases Can Impact a Patient’s Access to Preventative HIV Drug
A new study published today reveals systematic biases among primary and HIV care providers about people who inject drugs and how those biases may impact access to pre-exposure prophylaxis (PrEP), a preventive, prescription-based medication that significantly reduces the risk of HIV infection through sexual behavior and injection practices.
IHV Researchers Receive $6.5M to Create African Big Data Hub Designed to Address Public Health and Pandemic Preparedness
Researchers at the University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV), a Global Virus Network (GVN) Center of Excellence, have received $6.5 million from the U.S. National Institutes of Health (NIH) to streamline big data collection in Nigeria and South Africa in addressing public health needs of the COVID-19 and HIV pandemics.
Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
Neuroimaging study reveals potential brain mechanism underlying chronic neuropathic pain in individuals with HIV. Findings may guide new clinical treatments targeting patients’ expectations for pain relief.
UAlbany Receives $1M for Program to Prevent HIV and Substance Abuse
The University at Albany has been awarded $1 million for the creation of a five-year, comprehensive program aimed at preventing HIV infections and substance use disorders among students.
Virtual Village Treats HIV-associated Loneliness in Novel UC San Diego Health Trial
A new trial by UC San Diego Health infectious disease specialist Maile Young Karris, MD, will use longitudinal questionnaires and qualitative interviews to assess the impact of living in an interconnected virtual village on the loneliness known to afflict older people with HIV.
Einstein-Developed Treatment Strategy May Lead to HIV Cure
Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published today in the Journal of Clinical Investigation.
Crisis pregnancy centers may be hurting public health efforts
In recent years, crisis pregnancy centers (CPCs) have begun to offer some STI and HIV services, but new research from the University of Georgia suggests that these services may actually be hurting public health efforts to prevent and treat these infections.
Hopkins Med News Update
Hopkins Med News Update
Proteins that outwit emerging and re-emerging viruses
A family of proteins best known for their role in diminishing HIV infectivity may have the goods to outwit other emerging and re-emerging viruses, scientists have found.
Albert Einstein College of Medicine and City University of New York Researchers Receive $14.5 Million NIH Grant to Lead HIV Studies in Central Africa
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy (CUNYSPH) have been awarded a five-year, $14.5 million grant from the National Institutes of Health (NIH) to continue leading and expand their research on HIV treatment and care in five Central African nations.
Faculty Receives National Institutes of Health Grant to Assess the Implications of Opioid Use Among Older Adults Living with HIV
Rutgers School of Public Health assistant professor, Stephanie Shiau, has received a Career Development Award from the National Institute on Drug Abuse, part of the National Institutes of Health, to study the implications of opioid prescription use among older adults living with HIV.
BIDMC researchers awarded $24.5 million by NIH to find a cure for HIV
A team led by Dan H. Barouch, MD, PhD, has been awarded $4.9 million in annual funding over the next five years to find a cure for HIV. Barouch was one of ten primary investigators to receive a 2021 National Institutes of Health (NIH) Martin Delaney Collaboratories for HIV Cure Research award, which aims to expedite human immunodeficiency virus (HIV) cure research by bringing together research partners in academia, government, the private sector and the community; coordinating complex research studies, and mentoring the next generation of HIV cure researchers.
Hopkins Med News Update
NEWS STORIES IN THIS ISSUE:
– COVID-19 NEWS: Johns Hopkins Medicine Study Shows Vaccine Likely Protects People with HIV
– Johns Hopkins Medicine Documents Stroke Risk in Cardiac Assist Device
– CBD Products May Help People with Epilepsy Better Tolerate Anti-Seizure Medications
Dr. Chandra Ford – Founding Director, Center for the Study of Racism, Social Justice & Health, Professor of Community Health Sciences, UCLA Fielding School of Public Health, available as expert on health equity
Dr. Chandra Ford, founding director of the Center for the Study of Racism, Social Justice & Health and professor of Community Health Sciences, UCLA Fielding School of Public Health, is available as expert on health equity. Prof. Ford’s expertise includes:…
UCLA Fielding School Professor’s Team Awarded more than $5.2 Million in Grants for HIV Prevention
A team of researchers co-led by UCLA Fielding School of Public Health epidemiology professor Dr. Matthew Mimiaga has received more than $5.2 million in grants from the U.S. National Institutes of Health (NIH) to develop and test interventions in the U.S. and Brazil.
UM School Of Medicine Researchers Receive NIH Avant Garde Award For Out-Of-Box, Innovative Concept To Cure HIV And Treat Co-Existing Addiction
University of Maryland School of Medicine (UMSOM) Professor of Diagnostic Radiology & Nuclear Medicine, Linda Chang, MD, MS, received the National Institute on Drug Abuse (NIDA) 2021 Avant Garde Award (DP1) for HIV/AIDS and Substance Use Disorder Research — a National Institutes of Health (NIH) Director’s Pioneer Award.
Wistar Scientists Discover Blood-based Biomarkers to Predict HIV Remission After Stopping Antiretroviral Therapy
New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional cure. Wistar Scientists have identified metabolic and glycomic signatures in the blood of a rare population of HIV-infected individuals who can naturally sustain viral suppression after ART cessation, known as post-treatment controllers. T
People living with HIV/AIDS have a significantly higher risk of suicide
A new study by researchers at Penn State College of Medicine indicates that people living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) — approximately 38 million worldwide — are more likely to have suicidal thoughts and die from suicide than members of the general population.
Quarenta anos de HIV/AIDS
O mês de junho marca o 40º aniversário do primeiro relatório científico descrevendo a pneumocistose, que depois passou a ser conhecida como síndrome da imunodeficiência adquirida (AIDS).
Research provides a roadmap to HIV eradication via stem cell therapy
A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Undiagnosed and untreated disease identified in rural South Africa
A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.
Friend or foe? Seeliger probes the mysteries of mycobacteria
From studies in her lab at Stony Brook University in New York to private-sector collaborations, Hertz Fellow Jessica Seeliger is accelerating the fight against multiple deadly diseases.
Mobile care for persons with opioid use disorder aims to improve HIV prevention and treatment, and reduce opioid overdoses and deaths
A pilot study that hits the road to address two intersecting epidemics-– HIV among people who inject drugs and opioid dependence-– is underway at The University of Texas Health Science Center at Houston (UTHealth).
Perspectives on HIV/AIDS, 40 years after the first cases were officially reported
Saturday, June 5, marks the 40th anniversary of the first official reported cases of what became known as AIDS. The University of Michigan has experts who can discuss. Celeste Watkins-Hayes is a professor of public policy and sociology as well…